MedCity News
FEBRUARY 13, 2025
We need apps that have been tested with real users to ensure they are intuitive and easy to use. The apps also need to be designed to be inclusive of different needs including patients with disabilities, different levels of tech literacy, and diverse needs. The post Building Patient Trust in Digital Health Software appeared first on MedCity News.
PharmaVoice
FEBRUARY 13, 2025
The two companies will let their long-running contract expire this year, and drugmakers will need to decide which is the best platform for them in a changing marketplace.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
FEBRUARY 13, 2025
Medicare Advantage plans can more effectively position themselves for success under an evolving measurement system. Here are three strategic actions health plan leaders should prioritize to enhance 2026 bids to secure stronger Star Rating performance. The post The New Game Plan for Star Ratings Must Start with Member Incentives appeared first on MedCity News.
European Pharmaceutical Review
FEBRUARY 13, 2025
New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
FEBRUARY 13, 2025
GLP-1 drugs dominate the obesity market, but Aardvark Therapeutics aims to curb appetite by going after a different target: TAS2 receptors in the gut. The biotechs lead drug candidate is in Phase 3 testing in Prader-Willi syndrome, a genetic disorder that causes persistent hunger leading to overeating. The post Aardvark Therapeutics Pursuit of New Obesity Target Adds $94M in IPO Cash appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
FEBRUARY 13, 2025
The serial entrepreneur and CEO of Transcarent has dismissed care navigation companies in the past. What led him to buy Accolade, the biggest though struggling name in navigation? The post Is Glen Tullman a Hypocrite or a Victim of the System He Aimed to Disrupt? appeared first on MedCity News.
PharmaTimes
FEBRUARY 13, 2025
Imaging agent to improve prostate cancer detection
pharmaphorum
FEBRUARY 13, 2025
The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.
PharmaTimes
FEBRUARY 13, 2025
Significant progress for hereditary angioedema condition
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
FEBRUARY 13, 2025
Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.
PharmaTech
FEBRUARY 13, 2025
Investing in STEM programs for girls in an education setting and then supporting women as they excel in their professional careers is key to ensuring that vital highly skilled personnel are not left behind.
pharmaphorum
FEBRUARY 13, 2025
Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by E coli looks all but defunct after they abandon a phase 3 trial
Pharmaceutical Technology
FEBRUARY 13, 2025
AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based immunotherapies.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
pharmaphorum
FEBRUARY 13, 2025
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.
Pharmaceutical Technology
FEBRUARY 13, 2025
Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industrys top innovators reflect.
Pharmaceutical Commerce
FEBRUARY 13, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
FEBRUARY 13, 2025
SmartCella has secured exclusive rights to advance research around cell replacement therapies for the treatment of Parkinson's.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
FEBRUARY 13, 2025
In the fourth part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the value of FDA guidance documents for manufacturers, along with the areas of CGT development that would benefit most from standardization.
Pharmaceutical Technology
FEBRUARY 13, 2025
Speaking publicly for the first time about the USAID freeze, WHO director-general Dr Tedros has asked the US to reconsider its position.
Pharmacy Times
FEBRUARY 13, 2025
The agency will now review the novel PCSK9 inhibitor for possible approval in patients with or at high risk of atherosclerotic cardiovascular disease.
Pharmaceutical Technology
FEBRUARY 13, 2025
TriNetX has collaborated with Fujitsu to establish TriNetX Japan KK, a JV aimed at accelerating healthcare research and clinical trials.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
Pharmaceutical Technology
FEBRUARY 13, 2025
Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab.
Pharmacy Times
FEBRUARY 13, 2025
The expanding role of real-world evidence in regulatory and health technology assessment (HTA) decision-making highlights its growing acceptance for supplementing clinical trial data, addressing evidence gaps, and informing treatment value, despite challenges in data quality, accessibility, and regulatory compliance.
PharmaTech
FEBRUARY 13, 2025
This site was previously the beneficiary of a 7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
PharmExec
FEBRUARY 13, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
FEBRUARY 13, 2025
Andrew Lin, PharmD, BCOP, discusses his pharmacist-led study examining the association between early tacrolimus levels and outcomes post-allogeneic hematopoietic cell transplantation.
Expert insights. Personalized for you.
265 
Let's personalize your content